As the use of anti-obesity medications (AOMs) continues to grow, proprietary ADM Outside Voice research identifies product innovation opportunities to support people using these solutions and others who have transitioned off the drugs. The company notes that both consumer groups seek enjoyable, convenient, and portion-controlled functional products tailored to their needs. According to ADM’s research, 80% of consumers taking AOMs are willing to pay more for food and beverage products that provide added health attributes, with 67% saying that GLP-1-friendly attributes are now more important to them.
